Abstract
BackgroundIt is well established that methotrexate (MTX) co-medication improves efficacy of TNF-inhibitors (TNF-i) in rheumatoid arthritis, while in ankylosing spondylitis it is widely accepted that it does not. The role...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
